Logo

American Heart Association

  2
  0


Final ID: Mo2106

Claims-Based versus Registry-Reported Stroke Events in the NCDR Left Atrial Appendage Occlusion Registry

Abstract Body (Do not enter title and authors here): Background: Administrative claims data are increasingly used for post-marketing surveillance of drugs and medical devices, though data reliability remains uncertain. Given their associated morbidity and mortality, stroke events are particularly important to monitor for cardiovascular therapies such as transcatheter left atrial appendage occlusion (LAAO). However, there are limited data comparing stroke events in contemporary claims data to events reported in large nationwide registries with comprehensive data collection.

Aim: To compare stroke events in Medicare claims data with adjudicated registry-reported events in the National Cardiovascular Data Registry Left Atrial Appendage Occlusion (LAAO) Registry.

Methods: LAAO Registry data were linked with 2016-2022 Medicare inpatient claims. Primary diagnosis ICD-10 codes from inpatient hospitalizations were compared to adjudicated registry-reported ischemic and hemorrhagic stroke events occurring after discharge with up to two years of follow-up. In multiple secondary analyses, primary and secondary diagnosis codes were counted as events in claims data and patients with prior history of stroke were also excluded.

Results: The cohort included 71,043 adults ≥65 years old in the LAAO Registry with inpatient Medicare data. Following LAAO hospitalization discharge, there were 1405 claims-based and 1308 registry-reported total stroke events. Sensitivity and positive predictive value (PPV) of claims for identifying registry-reported events were 60.8% and 50.5% for ischemic stroke (kappa statistic 0.55), 42.7% and 50.5% for hemorrhagic stroke (kappa 0.46), and 58.1% and 54.1% for all stroke (kappa 0.55), respectively. Inclusion of secondary diagnosis codes improved sensitivity of claims (70.3% for ischemic stroke, 53.9% for hemorrhagic stroke and 67.0% for all stroke), but PPV decreased (44.8% for ischemic stroke, 34.8% for hemorrhagic stroke and 47.8% for all stroke). Specificity and negative predictive values of claims data were >98% for all stroke types. Findings were similar after excluding patients with prior history of stroke (Table).

Conclusions: Among Medicare patients in the LAAO Registry, administrative claims data had moderate agreement with adjudicated registry-reported stroke events. Claims data may not reliably capture all stroke events in real-world practice, and additional event ascertainment methods may be needed to ensure accurate assessment of stroke in post-marketing surveillance efforts.
  • Faridi, Kamil  ( YALE UNIVERSITY SCHOOL OF MEDICINE , Cheshire , Connecticut , United States )
  • Ross, Joseph  ( YALE UNIVERSITY SCHOOL MEDICINE , New Haven , Connecticut , United States )
  • Krumholz, Harlan  ( Yale University , New Haven , Connecticut , United States )
  • Yeh, Robert  ( Beth Israel Deaconess Med Ctr , Boston , Massachusetts , United States )
  • Curtis, Jeptha  ( YALE UNIVERSITY , New Haven , Connecticut , United States )
  • Freeman, James  ( YALE UNIV SCHOOL MEDICINE , New Haven , Connecticut , United States )
  • Wang, Yongfei  ( YALE UNIVERSITY SCHOOL OF MEDICINE , Cheshire , Connecticut , United States )
  • Pereira, Lucy  ( YALE CORE , New Haven , Connecticut , United States )
  • Zimmerman, Sarah  ( YALE CORE , New Haven , Connecticut , United States )
  • Friedman, Daniel  ( Duke University , Durham , North Carolina , United States )
  • Sharma, Richa  ( YALE UNIVERSITY SCHOOL OF MEDICINE , Cheshire , Connecticut , United States )
  • Higgins, Angela  ( Maine Medical Center , Portland , Maine , United States )
  • Mortazavi, Bobak  ( , College Station , Texas , United States )
  • Author Disclosures:
    Kamil Faridi: DO have relevant financial relationships ; Researcher:NIH/NHLBI:Active (exists now) | Joseph Ross: DO have relevant financial relationships ; Research Funding (PI or named investigator):Johnson and Johnson:Active (exists now) | Harlan Krumholz: DO have relevant financial relationships ; Individual Stocks/Stock Options:Element Science:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):Kenvue:Active (exists now) ; Research Funding (PI or named investigator):Janssen:Active (exists now) ; Ownership Interest:Ensight-AI:Active (exists now) ; Ownership Interest:Refactor Health:Active (exists now) ; Ownership Interest:Hugo Health:Active (exists now) ; Advisor:F-Prime:Active (exists now) ; Individual Stocks/Stock Options:Identifeye:Active (exists now) | Robert Yeh: DO have relevant financial relationships ; Consultant:abbott vascular :Active (exists now) ; Consultant:shiockwavw:Active (exists now) ; Consultant:cathworks:Active (exists now) ; Consultant:medronic:Active (exists now) ; Consultant:Boston scientific :Active (exists now) | Jeptha Curtis: DO NOT have relevant financial relationships | James Freeman: DO have relevant financial relationships ; Advisor:Boston Scientific:Active (exists now) ; Advisor:PaceMate:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Advisor:Biosense Webster:Active (exists now) | Yongfei Wang: DO NOT have relevant financial relationships | Lucy Pereira: No Answer | Sarah Zimmerman: DO NOT have relevant financial relationships | Daniel Friedman: DO have relevant financial relationships ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) ; Research Funding (PI or named investigator):Phillips:Active (exists now) ; Consultant:MicroPort CRM:Past (completed) ; Consultant:Alleviant:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Medtronic :Active (exists now) ; Consultant:Abbott:Active (exists now) ; Research Funding (PI or named investigator):Merit Medical:Past (completed) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) | Richa Sharma: DO NOT have relevant financial relationships | Angela Higgins: DO NOT have relevant financial relationships | Bobak Mortazavi: DO have relevant financial relationships ; Consultant:Abbott Diabetes Care:Active (exists now) ; Research Funding (PI or named investigator):NSF:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Ensight-AI:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

EP Potpourri #2

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A First-in-Class Humanized Antibody Fragment Targeting Platelet Glycoprotein Ibα: A Comprehensive Preclinical Study of CA1001 for the Treatment of Acute Ischemic Stroke

Xu Xiaohong, Preeti Preeti, Yu Ruoying, Shaykhalishahi Hamed, Zhang Cheng, Shen Chuanbin, Li Bei, Tang Naping, Chang Yan, Xiang Qian, Cui Yimin, Lei Xi, Ni Heyu, Zhu Guangheng, Liu Zhenze, Hu Xudong, Slavkovic Sladjana, Neves Miguel, Ma Wenjing, Xie Huifang

A ChatGLM-based stroke diagnosis and prediction tool

Song Xiaowei, Wang Jiayi, Ma Weizhi, Wu Jian, Wang Yueming, Gao Ceshu, Wei Chenming, Pi Jingtao

More abstracts from these authors:
Racial Disparities and Driving Factors in the AHA's Life's Essential 8 Among American Adults: Insights from NHANES 2011-2020

Yang Huanhuan, Huang Chenxi, Faridi Kamil, Spatz Erica, Li Zhiui, Krumholz Harlan, Lu Yuan

Long-Term Risks of Cardiovascular Disease in the U.S. Population Based on the American Heart Association PREVENT Equations

Faridi Kamil, Malik Devesh, Essa Mohammed, Yang Huanhuan, Spatz Erica, Krumholz Harlan, Lu Yuan

You have to be authorized to contact abstract author. Please, Login
Not Available